Ernexa Therapeutics (ERNA) Accounts Payables (2009 - 2026)
Ernexa Therapeutics' Accounts Payables was $1.38 million in Q2 2026, up 4.2% from $1.32 million a year earlier and up 5.8% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Accounts Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Ernexa Therapeutics came in at $1.13 million, down 34.6% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of -2.5% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $1.72 million in FY2024 (+61.3%), $1.07 million in FY2023 (-34.1%), $1.62 million in FY2022 (-7.7%) and $1.76 million in FY2021 (+37.6%).
- The Q2 2026 figure marks the highest quarterly Accounts Payables since Q4 2024.
- Compared with a year earlier, Accounts Payables was higher in four of the last eight quarters, with an average decline of 6.5%.
- The best year-over-year quarter for Accounts Payables over five years was Q3 2021 (growth of 262.3%); the worst was Q2 2022 (a decline of 59.8%).
- Per Business Quant data, ERNA's Accounts Payables in the three quarters before Q2 2026 was $1.3 million (Q1 2026), $1.13 million (Q4 2025) and $958,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.03 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -23.57 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Ernexa Therapeutics | 3.31 Mn | -18.41 Mn | - | 1.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.36 Mn |
| Jun 30, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 2.68 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.48 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 1.76 Mn |
API Access
Ernexa Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();